Show simple item record

dc.contributor.authorSwerdlow, A J
dc.contributor.authorHiggins, C D
dc.contributor.authorSmith, P
dc.contributor.authorCunningham, D
dc.contributor.authorHancock, B W
dc.contributor.authorHorwich, A
dc.contributor.authorHoskin, P J
dc.contributor.authorLister, T A
dc.contributor.authorRadford, John A
dc.contributor.authorRohatiner, A Z S
dc.contributor.authorLinch, D C
dc.date.accessioned2012-07-10T10:42:38Z
dc.date.available2012-07-10T10:42:38Z
dc.date.issued2011-11-01
dc.identifier.citationSecond cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. 2011, 29 (31):4096-104 J Clin Oncolen_GB
dc.identifier.issn1527-7755
dc.identifier.pmid21969511
dc.identifier.doi10.1200/JCO.2011.34.8268
dc.identifier.urihttp://hdl.handle.net/10541/232851
dc.description.abstractWe investigated the long-term risk of second primary malignancy after chemotherapy for Hodgkin's lymphoma (HL) in a much larger cohort than any yet published, to our knowledge.
dc.language.isoenen
dc.rightsArchived with thanks to Journal of clinical oncology : official journal of the American Society of Clinical Oncologyen_GB
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshCohort Studies
dc.subject.meshFemale
dc.subject.meshFollow-Up Studies
dc.subject.meshGreat Britain
dc.subject.meshHodgkin Disease
dc.subject.meshHumans
dc.subject.meshKaplan-Meier Estimate
dc.subject.meshLeukemia
dc.subject.meshLung Neoplasms
dc.subject.meshLymphoma, Non-Hodgkin
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasms, Second Primary
dc.subject.meshRadiotherapy, Adjuvant
dc.subject.meshRisk Assessment
dc.subject.meshRisk Factors
dc.subject.meshTime Factors
dc.subject.meshYoung Adult
dc.titleSecond cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.en
dc.typeArticleen
dc.contributor.departmentSection of Epidemiology, Sir Richard Doll Building, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom. anthony.swerdlow@icr.ac.uken_GB
dc.identifier.journalJournal of Clinical Oncologyen_GB
html.description.abstractWe investigated the long-term risk of second primary malignancy after chemotherapy for Hodgkin's lymphoma (HL) in a much larger cohort than any yet published, to our knowledge.


This item appears in the following Collection(s)

Show simple item record